CareDx Inc. (CDNA) exhibits 41.0% gross margins and -8.2% return on invested capital within Health Care (Medical Specialities), balanced against a 24.0x enterprise multiple and 7.1% implied options volatility.
Sustained 41.0% gross profitability converts into -8.1% operating margin and -8.2% ROIC, outpacing sector cost of capital.
ROIC: -8.2% // GM: 41.0%YoY revenue trajectory of +13.8% paired with 0.67% free cash flow yield supports self-funded R&D and capital return.
REV YOY: +13.8% // FCF YLD: 0.67%Altman Z-Score of 19.22 and Piotroski F-Score of 7/9 indicate low near-term refinancing stress.
ALTMAN Z: 19.22 // F-SCORE: 7/9Trading at 24.0x trailing P/E (21.0x Fwd P/E) leaves valuation vulnerable if real 10Y TIPS yields spike.
P/E: 24.0x // EV/EBITDA: —Options market prices a ±7.1% implied move with a 0.80 put/call ratio around $70.00 max pain.
IMPL MOVE: ±7.1% // P/C: 0.80Elevated industry capital intensity and customer concentration in Medical Specialities require continuous execution to defend -5.6% net margins.
NET MARGIN: -5.6% // D/E: 0.15x| FILER | SIDE | $ VALUE |
|---|---|---|
| INSPECT FULL OWNERSHIP LEDGER IN OWN <GO> | ||
| STRIKE / EXP | TYPE | PREMIUM |
|---|---|---|
| INSPECT GEX & CHAIN IN OPT <GO> | ||
Unblur the exact $50,000 delta-adjusted ETF/options hedge ratio for CDNA & activate live FRED threshold breach alerts.